News | July 16, 2022
Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Govt committed to supporting pharma companies with industry-friendly policies
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The drug will be available in 600 hospitals and 105 DTPs
The company exports mobile surgery equipment to over 100 countries from Pune
Subscribe To Our Newsletter & Stay Updated
